The optimal P3M algorithm for computing electrostatic energies in periodic systems

Autor: Ballenegger, V., Cerda, J. J., Holm, Ch., Lenz, O.

Publikováno v: J. Chem. Phys. 128, 034109 (2008)

We optimize Hockney and Eastwood's Particle-Particle Particle-Mesh (P3M) algorithm to achieve maximal accuracy in the electrostatic energies (instead of forces) in 3D periodic charged systems. To this end we construct an optimal influence function th

Externí odkaz: http://arxiv.org/abs/0708.0728

Modeling strategies for polyelectrolyte multilayers

Autor: Cerdà, J. J., Qiao, B., Holm, Ch., Cerdà, J. J., Qiao, B., Holm, Ch.

Publikováno v: European Physical Journal Special Topics; October 2009, Vol. 177 Issue: 1 p129-148, 20p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.

Autor: Moustsen-Helms IR; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Bager P; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark., Larsen TG; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark; ECDC Fellowship Programme, Public Health Microbiology path (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Møller FT; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Vestergaard LS; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Rasmussen M; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark., Hansen CH; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark; MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: choh@ssi.dk.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. 964-973. Date of Electronic Publication: 2024 May 15.

Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study.

Autor: Armenteros JJA; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Brorsson C; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Johansen CH; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Banasik K; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Mazzoni G; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Moulder R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Hirvonen K; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Suomi T; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Rasool O; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Bruggraber SFA; Department of Paediatrics, University of Cambridge, Cambridge, England., Marcovecchio ML; Department of Paediatrics, University of Cambridge, Cambridge, England., Hendricks E; Department of Paediatrics, University of Cambridge, Cambridge, England., Al-Sari N; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Mattila I; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Legido-Quigley C; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Suvitaival T; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Chmura PJ; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Knip M; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Pediatric Research Center, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland., Schulte AM; Bayer Pharmaceuticals, Berlin, Germany., Lee JH; Immunology & Inflammation Research Therapeutic Area, Sanofi, Massachusetts, USA., Sebastiani G; Department of Medicine, Surgery and Neuroscience, Università degli Studi di Siena, Siena, Italy.; Fondazione Umberto di Mario, ONLUS - Toscana Life Sciences, Siena, Italy., Grieco GE; Department of Medicine, Surgery and Neuroscience, Università degli Studi di Siena, Siena, Italy.; Fondazione Umberto di Mario, ONLUS - Toscana Life Sciences, Siena, Italy., Elo LL; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland., Kaur S; Steno Diabetes Center Copenhagen, Herlev University Hospital, Herlev, Denmark., Pociot F; Steno Diabetes Center Copenhagen, Herlev University Hospital, Herlev, Denmark., Dotta F; Department of Medicine, Surgery and Neuroscience, Università degli Studi di Siena, Siena, Italy.; Tuscany Centre for Precision Medicine (CReMeP), Siena, Italy., Tree T; Department of Immunobiology, King's College, London, UK., Lahesmaa R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Overbergh L; Department of Chronic Diseases and Metabolism, Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium., Mathieu C; Department of Chronic Diseases and Metabolism, Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium., Peakman M; Immunology & Inflammation Research Therapeutic Area, Sanofi, Massachusetts, USA.; Department of Immunobiology, King's College, London, UK., Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Jul; Vol. 40 (5), pp. e3833.